Cepheid is a global leader in molecular diagnostics, dedicated to improving healthcare through fast, accurate, and accessible diagnostic testing. The company develops and manufactures integrated systems and tests that enable the rapid detection of infectious diseases, oncology markers, and other critical health conditions. Through its flagship GeneXpert® platform, Cepheid simplifies complex molecular testing and delivers reliable results closer to the patient, helping healthcare professionals make faster treatment decisions. Cepheid is part of Danaher and operates in more than 100 countries worldwide.